ANIKA THERAPEUTICS INC (ANIK) — insider trading
Health Care · NASDAQ
ANIKA THERAPEUTICS INC (ANIK) has 31 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases among the most recent 31 (latest 2026-06-18).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | CONLEY SHERYL L | Director | Grant / award / vesting | 10,402 | $0.00 | $0 | Form 4 |
| 2026-06-18 | Capper Joseph H | Director | Grant / award / vesting | 10,402 | $0.00 | $0 | Form 4 |
| 2026-06-18 | Richard Stephen | Director | Grant / award / vesting | 10,402 | $0.00 | $0 | Form 4 |
| 2026-06-18 | HENNEMAN JOHN B III | Director | Grant / award / vesting | 10,402 | $0.00 | $0 | Form 4 |
| 2026-06-18 | Fischetti Gary P | Director | Grant / award / vesting | 10,402 | $0.00 | $0 | Form 4 |
| 2026-06-03 | Griffin Stephen D. | Director, Officer (President and CEO) | Option exercise / conversion (derivative) | 12,840 | $0.00 | $0 | Form 4 |
| 2026-06-03 | Griffin Stephen D. | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 3,769 | $14.41 | $54.3K | Form 4 |
| 2026-06-03 | Griffin Stephen D. | Director, Officer (President and CEO) | Option exercise / conversion | 12,840 | — | — | Form 4 |
| 2026-05-01 | HENNEMAN JOHN B III | Director | Open-market purchase | 5,000 | $14.66 | $73.3K | Form 4 |
| 2026-04-30 | Griffin Stephen D. | Director, Officer (President and CEO) | Open-market purchase | 12,200 | $12.29 | $149.9K | Form 4 |
| 2026-03-19 | McLeod Ian | Officer (SVP, CAO & Treasurer) | Grant / award / vesting (derivative) | 17,663 | $0.00 | $0 | Form 4 |
| 2026-03-19 | McLeod Ian | Officer (SVP, CAO & Treasurer) | Grant / award / vesting (derivative) | 11,194 | $0.00 | $0 | Form 4 |
| 2026-03-19 | McLeod Ian | Officer (SVP, CAO & Treasurer) | Grant / award / vesting (derivative) | 13,097 | $0.00 | $0 | Form 4 |
| 2026-03-15 | Blanchard Cheryl R | Director | Option exercise / conversion (derivative) | 25,131 | $0.00 | $0 | Form 4 |
| 2026-03-15 | Blanchard Cheryl R | Director | Shares withheld for taxes / exercise cost | 12,104 | $14.20 | $171.9K | Form 4 |
| 2026-03-15 | Blanchard Cheryl R | Director | Option exercise / conversion | 25,131 | — | — | Form 4 |
| 2026-03-15 | Colleran David | Officer (EVP, General Counsel, Corp Sec) | Option exercise / conversion (derivative) | 6,449 | $0.00 | $0 | Form 4 |
| 2026-03-15 | Colleran David | Officer (EVP, General Counsel, Corp Sec) | Shares withheld for taxes / exercise cost | 1,893 | $14.20 | $26.9K | Form 4 |
| 2026-03-15 | Colleran David | Officer (EVP, General Counsel, Corp Sec) | Option exercise / conversion | 6,449 | — | — | Form 4 |
| 2026-03-14 | Blanchard Cheryl R | Director | Option exercise / conversion (derivative) | 24,519 | $0.00 | $0 | Form 4 |
| 2026-03-14 | Blanchard Cheryl R | Director | Shares withheld for taxes / exercise cost | 14,728 | $14.20 | $209.1K | Form 4 |
| 2026-03-14 | Blanchard Cheryl R | Director | Grant / award / vesting | 24,520 | $0.00 | $0 | Form 4 |
| 2026-03-14 | Blanchard Cheryl R | Director | Option exercise / conversion | 24,519 | — | — | Form 4 |
| 2026-03-14 | Griffin Stephen D. | Director, Officer (President and CEO) | Option exercise / conversion (derivative) | 12,824 | $0.00 | $0 | Form 4 |
| 2026-03-14 | Griffin Stephen D. | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 5,944 | $14.20 | $84.4K | Form 4 |
| 2026-03-14 | Griffin Stephen D. | Director, Officer (President and CEO) | Grant / award / vesting | 6,412 | $0.00 | $0 | Form 4 |
| 2026-03-14 | Griffin Stephen D. | Director, Officer (President and CEO) | Option exercise / conversion | 12,824 | — | — | Form 4 |
| 2026-03-14 | Colleran David | Officer (EVP, General Counsel, Corp Sec) | Option exercise / conversion (derivative) | 9,388 | $0.00 | $0 | Form 4 |
| 2026-03-14 | Colleran David | Officer (EVP, General Counsel, Corp Sec) | Shares withheld for taxes / exercise cost | 4,168 | $14.20 | $59.2K | Form 4 |
| 2026-03-14 | Colleran David | Officer (EVP, General Counsel, Corp Sec) | Grant / award / vesting | 4,694 | $0.00 | $0 | Form 4 |
| 2026-03-14 | Colleran David | Officer (EVP, General Counsel, Corp Sec) | Option exercise / conversion | 9,388 | — | — | Form 4 |
Ask the chat about ANIK's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ANIKA THERAPEUTICS INC (ANIK).
Last updated 2026-06-18 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.